ACCELERON PHARMA INC. Net Income (Loss) Available to Common Stockholders, Basic
ACCELERON PHARMA INC. reported Net Income (Loss) Available to Common Stockholders, Basic of -$25.41 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-08.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2017-05-08
- ACCELERON PHARMA INC. net income (loss) available to common stockholders, basic for the quarter ending 2017-03-31 was -$25.41M, a 602.02% decline year-over-year.
- ACCELERON PHARMA INC. net income (loss) available to common stockholders, basic for the quarter ending 2016-03-31 was $5.06M.
- ACCELERON PHARMA INC. net income (loss) available to common stockholders, basic for the quarter ending 2015-03-31 was -$14.57M.
- ACCELERON PHARMA INC. net income (loss) available to common stockholders, basic for the quarter ending 2014-12-31 was -$17.62M.
- ACCELERON PHARMA INC. net income (loss) available to common stockholders, basic for fiscal 2015 was -$63.89M.
- ACCELERON PHARMA INC. net income (loss) available to common stockholders, basic for fiscal 2014 was -$51.26M.
- ACCELERON PHARMA INC. net income (loss) available to common stockholders, basic for fiscal 2013 was -$39.00M.
- ACCELERON PHARMA INC. net income (loss) available to common stockholders, basic for fiscal 2012 was -$59.64M, a 3299.73% decline from fiscal 2011.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$25.41M 10-Q · filed 2017-05-08 | |||
| 2016-03-31 | $5.06M 10-Q · filed 2017-05-08 | |||
| 2015-12-31 | -$63.89M 10-K · filed 2016-02-25 | |||
| 2015-03-31 | -$14.57M 10-Q · filed 2016-05-05 | -$32.19M derived: sum of 2 quarters · filed 2016-05-05 | -$40.16M derived: sum of 3 quarters · filed 2016-05-05 | -$56.71M derived: sum of 4 quarters · filed 2016-05-05 |
| 2014-12-31 | -$17.62M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$25.59M derived: sum of 2 quarters · filed 2016-02-25 | -$42.14M derived: sum of 3 quarters · filed 2016-02-25 | -$51.26M 10-K · filed 2016-02-25 |
| 2014-09-30 | -$7.97M 10-Q · filed 2014-11-07 | -$24.52M derived: sum of 2 quarters · filed 2014-11-07 | -$33.64M 10-Q · filed 2014-11-07 | -$51.75M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | -$16.55M 10-Q · filed 2014-08-12 | -$25.67M 10-Q · filed 2014-08-12 | -$43.78M derived: sum of 3 quarters · filed 2016-02-25 | -$68.56M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$9.12M 10-Q · filed 2014-05-15 | -$27.23M derived: sum of 2 quarters · filed 2016-02-25 | -$52.02M derived: sum of 3 quarters · filed 2016-02-25 | -$51.27M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | -$18.11M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$42.90M derived: sum of 2 quarters · filed 2016-02-25 | -$42.15M derived: sum of 3 quarters · filed 2016-02-25 | -$39.00M 10-K · filed 2016-02-25 |
| 2013-09-30 | -$24.79M 10-Q · filed 2014-11-07 | -$24.04M derived: sum of 2 quarters · filed 2014-11-07 | -$20.89M 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $743.00K 10-Q · filed 2014-08-12 | $463.00K 10-Q · filed 2014-08-12 | ||
| 2013-03-31 | -$2.34M 10-Q · filed 2014-05-15 | |||
| 2012-12-31 | -$59.64M 10-K · filed 2015-03-02 | |||
| 2011-12-31 | $1.86M 10-K · filed 2014-03-17 |